Clinical Trial Update: The Effects of Adding TCM-700C on the Standard Combination Treatment for Patients With Genotype 1 Hepatitis C Infection [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating adding TCM-700C to standard treatment for genotype 1 chronic hepatitis C. Results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• TCM-700C

Snippet

Sponsor: TCM Biotech International Corp. | Conditions: Chronic Hepatitis C | Phase 2 | Status: COMPLETED | Results posted: 2014-07-08